Preferred Reporting Items For Systematic Review And Meta-Analysis Protocols (PRISMA-P) 2015 Statement

·2015·DOI
Health Sciences and Innovation
Health Sciences
Systematic Reviews and Meta-Analysis
Comprehensive Meta-Analysis Studies

Role in the Field

Neutralin Health Sciences and Innovation
Neutralin Health Sciences
Neutralin Systematic Reviews and Meta-Analysis
Neutralin Comprehensive Meta-Analysis Studies

Abstract

Citations

18,188

Year

2015

PageRank

5.2 / 10

Relative influence (log-scaled)

Related Papers

10 of 10 papers

Rigour And Transparency In The Family Of Systematic Reviews: The International Journal Of Health Planning And Management Encourages Prospective Protocol Registration
·2021·40,920 citations
RoB 2: A Revised Tool For Assessing Risk Of Bias In Randomised Trials
·2019·18,583 citations
Critical Evaluation Of The Newcastle-Ottawa Scale For The Assessment Of The Quality Of Nonrandomized Studies In Meta-Analyses
·2010·12,798 citations
The PRISMA Statement For Reporting Systematic Reviews And Meta-Analyses Of Studies That Evaluate Health Care Interventions: Explanation And Elaboration
·2009·13,142 citations
Quantifying Heterogeneity In A Meta-Analysis
·2002·29,093 citations
Meta-analysis Of Observational Studies In Epidemiology<SUBTITLE>A Proposal For Reporting</SUBTITLE>
·2000·18,158 citations
Bias In Meta-Analysis Detected By A Simple, Graphical Test
·1997·44,632 citations
Assessing The Quality Of Reports Of Randomized Clinical Trials: Is Blinding Necessary?
·1996·13,214 citations
Meta-analysis In Clinical Trials
·1986·33,395 citations
Design And Analysis Of Randomized Clinical Trials Requiring Prolonged Observation Of Each Patient. II. Analysis And Examples
·1977·9,788 citations